Counter-intuitively, TIGIT gene expression was associated with improved recurrence-free survival (RFS) and OS in basal-like breast cancers (25), a subpopulation that predominantly includes TNBC, and also in a cohort of patients with all breast cancer types (24). This evidence concerns the gene TIGIT and breast carcinoma.